Author Index
Search or browse for an author across our entire electronic archive
Search results for: Y
Results 51 - 60 of 434 shown below
Yamamoto, J
H Ueno, T Kosuge, Y Matsuyama, J Yamamoto, A Nakao, S Egawa, R Doi, M Monden, T Hatori, M Tanaka, M Shimada and K Kanemitsu
A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer
advance online publication, 2009-08-18 00:00:00.000;
doi:10.1038/sj.bjc.6605256
Abstract | Full article | PDF
Yamamoto, K
H Katori, M Tsukuda, I Mochimatu, J Ishitoya, S Kawai, Y Mikami, H Matsuda, Y Tanigaki, C Horiuchi, Y Ikeda, T Taguchi, M Ono, T Yoshida, S Hirose, Y Sakuma and K Yamamoto
Phase I trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)
doi:10.1038/sj.bjc.6601471
Abstract | Full article | PDF
-
T Iehara, H Hosoi, K Akazawa, Y Matsumoto, K Yamamoto, S Suita, T Tajiri, T Kusafuka, E Hiyama, M Kaneko, F Sasaki, T Sugimoto and T Sawada
MYCN gene amplification is a powerful prognostic factor even in infantile neuroblastoma detected by mass screening
advance online publication, 2006-05-02 00:00:00.000;
doi:10.1038/sj.bjc.6603149
Abstract | Full article | PDF
-
K Nouso, Y M Ito, K Kuwaki, Y Kobayashi, S Nakamura, Y Ohashi and K Yamamoto
Prognostic factors and treatment effects for hepatocellular carcinoma in Child C cirrhosis
advance online publication, 2008-03-18 00:00:00.000;
doi:10.1038/sj.bjc.6604282
Abstract | Full article | PDF
-
N Iizuka, K Hirose, T Noma, S Hazama, A Tangoku, H Hayashi, T Abe, K Yamamoto and M Oka
The nm23-H1 gene as a predictor of sensitivity to chemotherapeutic agents in oesophageal squamous cell carcinoma
doi:10.1038/sj.bjc.6690717
-
T Kato, T Kimura, R Miyakawa, A Fujii, K Yamamoto, S Kameoka, T Nishikawa and T Kasajima
Clinicopathologic study associated with long-term survival in Japanese patients with node-negative breast cancer
doi:10.1054/bjoc.1999.0934
-
H Tsuda, K Yamamoto, T Inoue, I Uchiyama and N Umesaki
The role of p16-cyclin D/CDK-pRb pathway in the tumorigenesis of endometrioid-type endometrial carcinoma
doi:10.1054/bjoc.1999.0980
-
N Toshikuni, K Nouso, T Higashi, H Nakatsukasa, T Onishi, T Kaneyoshi, Y Kobayashi, K Kariyama, K Yamamoto and T Tsuji
Expression of telomerase-associated protein 1 and telomerase reverse transcriptase in hepatocellular carcinoma
doi:10.1054/bjoc.1999.1008
-
N Mori, M Oka, S Hazama, N Iizuka, K Yamamoto, S Yoshino, A Tangoku, T Noma and K Hirose
Detection of telomerase activity in peritoneal lavage fluid from patients with gastric cancer using immunomagnetic beads
doi:10.1054/bjoc.2000.1408
Yamamoto, M
R Suzuki, Y Hasegawa, K Baba, H Saka, H Saito, H Taniguchi, M Yamamoto, S Matsumoto, K Kato, T Oishi, K Imaizumi and K Shimokata
A phase II study of single-agent gefitinib as first-line therapy in patients with stage IV non-small-cell lung cancer
advance online publication, 2006-05-02 00:00:00.000;
doi:10.1038/sj.bjc.6603159
Abstract | Full article | PDF
-
K Fujita, K Denda, M Yamamoto, T Matsumoto, M Fujime and T Irimura
Expression of MUC1 mucins inversely correlated with post-surgical survival of renal cell carcinoma patients
doi:10.1038/sj.bjc.6690355
Yamamoto, N
M Yamada, S Kudoh, H Fukuda, K Nakagawa, N Yamamoto, Y Nishimura, S Negoro, K Takeda, M Tanaka and M Fukuoka
Dose-escalation study of weekly irinotecan and daily carboplatin with concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer
doi:10.1038/sj.bjc.6600464
Abstract | Full article | PDF
-
N Yamamoto, M Fukuoka, S-I Negoro, K Nakagawa, H Saito, K Matsui, M Kawahara, H Senba, Y Takada, S Kudoh, T Nakano, N Katakami, T Sugiura, T Hoso and Y Ariyoshi
Randomised phase II study of docetaxel/cisplatin vs docetaxel/irinotecan in advanced non-small-cell lung cancer: a West Japan Thoracic Oncology Group Study (WJTOG9803)
doi:10.1038/sj.bjc.6601462
Abstract | Full article | PDF
-
K Nakagawa, S Kudoh, K Matsui, S Negoro, N Yamamoto, J E Latz, S Adachi and M Fukuoka
A phase I study of pemetrexed (LY231514) supplemented with folate and vitamin B12 in Japanese patients with solid tumours
advance online publication, 2006-08-29 00:00:00.000;
doi:10.1038/sj.bjc.6603321
Abstract | Full article | PDF
-
I Sekine, N Yamamoto, K Nishio and N Saijo
Emerging ethnic differences in lung cancer therapy
advance online publication, 2008-11-04 00:00:00.000;
doi:10.1038/sj.bjc.6604721
Abstract | Full article | PDF
-
C Tanai, H Nokihara, S Yamamoto, H Kunitoh, N Yamamoto, I Sekine, Y Ohe and T Tamura
Characteristics and outcomes of patients with advanced non-small-cell lung cancer who declined to participate in randomised clinical chemotherapy trials
advance online publication, 2009-03-17 00:00:00.000;
doi:10.1038/sj.bjc.6604982
Abstract | Full article | PDF
-
F Ohyanagi, N Yamamoto, A Horiike, H Harada, T Kozuka, H Murakami, K Gomi, T Takahashi, M Morota, T Nishimura, M Endo, Y Nakamura, A Tsuya, T Horai and M Nishio
Phase II trial of S-1 and cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer
doi:10.1038/sj.bjc.6605152
Abstract | Full article | PDF
-
N Yamamoto, K Uzawa, T Yakushiji, T Shibahara, H Noma and H Tanzawa
Analysis of the ANA gene as a candidate for the chromosome 21q oral cancer susceptibility locus
doi:10.1054/bjoc.2000.1656
Yamamoto, S
Y Tsubono, T Otani, M Kobayashi, S Yamamoto, T Sobue and S Tsugane
No association between fruit or vegetable consumption and the risk of colorectal cancer in Japan
advance online publication, 2005-04-26 00:00:00.000;
doi:10.1038/sj.bjc.6602566
Abstract | Full article | PDF
-
C Tanai, H Nokihara, S Yamamoto, H Kunitoh, N Yamamoto, I Sekine, Y Ohe and T Tamura
Characteristics and outcomes of patients with advanced non-small-cell lung cancer who declined to participate in randomised clinical chemotherapy trials
advance online publication, 2009-03-17 00:00:00.000;
doi:10.1038/sj.bjc.6604982
Abstract | Full article | PDF
-
J Kurebayashi, S Yamamoto, T Otsuki and H Sonoo
Medroxyprogesterone acetate inhibits interleukin 6 secretion from KPL-4 human breast cancer cells both in vitro and in vivo: a possible mechanism of the anticachectic effect
doi:10.1038/sj.bjc.6690099
-
J Kurebayashi, T Otsuki, M Kurosumi, S Yamamoto, K Tanaka, M Mochizuki and H Nakamura
Isolation and characterization of a new human breast cancer cell line, KPL-4, expressing the Erb B family receptors and interleukin-6
doi:10.1038/sj.bjc.6690114
-
H Kunisue, J Kurebayashi, T Otsuki, C K Tang, M Kurosumi, S Yamamoto, K Tanaka, H Doihara, N Shimizu and H Sonoo
Anti-HER2 antibody enhances the growth inhibitory effect of anti-oestrogen on breast cancer cells expressing both oestrogen receptors and HER2
doi:10.1054/bjoc.1999.0875
-
T Kawaguchi, S Yamamoto, N Naka, K Okishio, S Atagi, M Ogawara, S Hosoe, M Kawahara and K Furuse
Immunohistochemical analysis of Bcl-2 protein in early squamous cell carcinoma of the bronchus treated with photodynamic therapy
doi:10.1054/bjoc.1999.0936
Yamamoto, T
K Kaneko, H Ito, K Konishi, T Kurahashi, T Ito, A Katagiri, T Yamamoto, T Kitahara, Y Mizutani, A Ohtsu and K Mitamura
Definitive chemoradiotherapy for patients with malignant stricture due to T3 or T4 squamous cell carcinoma of the oesophagus
doi:10.1038/sj.bjc.6600684
Abstract | Full article | PDF
-
T Uenishi, S Kubo, K Hirohashi, H Tanaka, T Shuto, T Yamamoto and S Nishiguchi
Cytokeratin-19 fragments in serum (CYFRA 21-1) as a marker in primary liver cancer
doi:10.1038/sj.bjc.6601026
Abstract | Full article | PDF
-
T Yamamoto, K Konishi, T Yamochi, R Makino, K Kaneko, T Shimamura, H Ota and K Mitamura
No major tumorigenic role for
-catenin in serrated as opposed to conventional colorectal adenomasdoi:10.1038/sj.bjc.6601070
Abstract | Full article | PDF
-
H Ota, H Nagano, M Sakon, H Eguchi, M Kondo, T Yamamoto, M Nakamura, B Damdinsuren, H Wada, S Marubashi, A Miyamoto, K Dono, K Umeshita, S Nakamori, K Wakasa and M Monden
Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-
and intra-arterial 5-fluorouracil; role of type 1 interferon receptor expressionadvance online publication, 2005-08-16 00:00:00.000;
doi:10.1038/sj.bjc.6602742
Abstract | Full article | PDF
-
K Konishi, M Takimoto, K Kaneko, R Makino, Y Hirayama, H Nozawa, T Kurahashi, Y Kumekawa, T Yamamoto, H Ito, N Yoshikawa, M Kusano, K Nakayama, B J Rembacken, H Ota and M Imawari
BRAF mutations and phosphorylation status of mitogen-activated protein kinases in the development of flat and depressed-type colorectal neoplasias
advance online publication, 2005-12-13 00:00:00.000;
doi:10.1038/sj.bjc.6602911
Abstract | Full article | PDF
-
K Kaneko, A Katagiri, K Konishi, T Kurahashi, H Ito, Y Kumekawa, T Yamamoto, T Muramoto, Y Kubota, H Nozawa, R Makino, M Kushima and M Imawari
Study of p53 gene alteration as a biomarker to evaluate the malignant risk of Lugol-unstained lesion with non-dysplasia in the oesophagus
doi:10.1038/sj.bjc.6603582
Abstract | Full article | PDF
Yamamoto, Y
T Kubota, H Fujiwara, Y Ueda, T Itoh, T Yamashita, T Yoshimura, K Okugawa, Y Yamamoto, Y Yano and H Yamagishi
Cimetidine modulates the antigen presenting capacity of dendritic cells from colorectal cancer patients
doi:10.1038/sj.bjc.6600233
Abstract | Full article | PDF
-
M Shimamura, H Nagasawa, H Ashino, Y Yamamoto, T Hazato, Y Uto, H Hori and S Inayama
A novel hypoxia-dependent 2-nitroimidazole KIN-841 inhibits tumour-specific angiogenesis by blocking production of angiogenic factors
doi:10.1038/sj.bjc.6600667
Abstract | Full article | PDF
-
S Okubo, J Kurebayashi, T Otsuki, Y Yamamoto, K Tanaka and H Sonoo
Additive antitumour effect of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib (Iressa, ZD1839) and the antioestrogen fulvestrant (Faslodex, ICI 182,780) in breast cancer cells
doi:10.1038/sj.bjc.6601504
Abstract | Full article | PDF
-
K Ota, H Fujimori, M Ueda, S Shiniriki, M Kudo, H Jono, Y Fukuyoshi, Y Yamamoto, H Sugiuchi, H Iwase, M Shinohara and Y Ando
Midkine as a prognostic biomarker in oral squamous cell carcinoma
advance online publication, 2008-08-05 00:00:00.000;
doi:10.1038/sj.bjc.6604539
Abstract | Full article | PDF
Yamamoto-Yamaguchi, Y
Y Honma, Y Yamamoto-Yamaguchi and Y Kanatani
Vesnarinone and glucocorticoids cooperatively induce G1 arrest and have an anti-tumour effect on human non-small cell lung carcinoma cells grown in nude mice
doi:10.1038/sj.bjc.6690327
Yamamura, Y
S Ito, H Nakanishi, Y Kodera, Y Mochizuki, M Tatematsu and Y Yamamura
Prospective validation of quantitative CEA mRNA detection in peritoneal washes in gastric carcinoma patients
advance online publication, 2005-10-04 00:00:00.000;
doi:10.1038/sj.bjc.6602802
Abstract | Full article | PDF
-
N Futamura, S Nakamura, M Tatematsu, Y Yamamura, R Kannagi and H Hirose
Clinicopathologic significance of sialyl Le xexpression in advanced gastric carcinoma
doi:10.1054/bjoc.2000.1484
Yamana, H
Y Maeda, N Hida, F Niiya, K Katagiri, M Harada, H Yamana, T Kamura, M Takahashi, Y Sato, S Todo and K Itoh
Detection of peptide-specific CTL-precursors in peripheral blood lymphocytes of cancer patients
doi:10.1038/sj.bjc.6600548
Abstract | Full article | PDF
